Fulgent Genetics Inc. (FLGT)
NASDAQ: FLGT
· Real-Time Price · USD
22.78
-0.12 (-0.52%)
At close: Oct 03, 2025, 3:59 PM
22.78
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
-0.52% (1D)
| Bid | 22.41 |
| Market Cap | 697.27M |
| Revenue (ttm) | 303.22M |
| Net Income (ttm) | -51.02M |
| EPS (ttm) | -1.72 |
| PE Ratio (ttm) | -13.24 |
| Forward PE | -34.7 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 23.5 |
| Volume | 151,353 |
| Avg. Volume (20D) | 272,773 |
| Open | 22.92 |
| Previous Close | 22.90 |
| Day's Range | 22.63 - 23.25 |
| 52-Week Range | 14.57 - 23.57 |
| Beta | 0.98 |
| Ex-Dividend Date | n/a |
About FLGT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FLGT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FLGT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsFulgent Genetics Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+13.18%
Fulgent Genetics shares are trading higher after U...
Unlock content with
Pro Subscription
2 months ago
+7.86%
Fulgent Genetics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance above estimates.
2 months ago · fool.com
Fulgent (FLGT) Q2 Revenue Jumps 16%Fulgent (FLGT) Q2 Revenue Jumps 16%
2 months ago · businesswire.com
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLMEL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeuti...
2 months ago · businesswire.com
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic...